High Prevalence of HCV in Baby Boomers Presenting to ER

This article originally appeared here.
Share this content:
High Prevalence of HCV in Baby Boomers Presenting to ER
High Prevalence of HCV in Baby Boomers Presenting to ER

MONDAY, March 2, 2015 (HealthDay News) -- The prevalence of unrecognized chronic hepatitis C virus (HCV) is high among baby boomers presenting to the emergency department, according to a study published online Jan. 28 in Hepatology.

James W. Galbraith, M.D., from the University of Alabama School of Medicine in Birmingham, and colleagues describe an early experience with integrated opt-out HCV antibody (Ab) screening of medically stable baby boomers presenting to an urban academic emergency department. The researchers examined the prevalence of unrecognized HCV infection.

The researchers found that 12.7 percent of the 2,325 HCV-unaware baby boomers opted out of HCV screening. HCV Ab tests were performed on 1,529 individuals, 170 (11.1 percent) of whom were reactive. Follow-up polymerase chain reaction was performed on 150 patients, of whom 68 percent were confirmed RNA-positive. The likelihood of HCV was higher for males versus females (14.7 versus 7.4 percent), for African-Americans versus whites (13.3 versus 8.8 percent), and for under/uninsured versus insured patients (16.8/16.9 versus 5 percent). Fifty-four percent of RNA-positive patients were successfully contacted by phone within five attempts. Initial follow-up appointments were confirmed for 70.3 percent of RNA-positive individuals who had been successfully contacted.

"We observed high prevalence of unrecognized chronic HCV infection in this series of baby boomers presenting to the emergency department, highlighting the emergency department as an important venue for high-impact HCV screening and linkage to care," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »